Evaluating Existing Safety Surveillance Regulations for Drug Development
UBC’s pharmacovigilance experts compare current safety regulations in Advances in Therapy.
External Controls in Research: The “What, Why and How”
Experts across various domains come together to discuss and highlight various key aspects of using external control arms.
EHR Data & the Importance of Case Definitions in Disease Surveillance
Read the UBC staff publication in the International Journal of Medical Informatics on this topic.
Why Integrated Registries are Critical for Rare Disease
Learn more in this article from UBC’s Evidence Development team in International Clinical Trials Magazine.
The Impact of Real World Data (RWD)
Read the latest article with International Clinical Trials magazine about real-world data and the future of evidence generation in drug development.
UBC’s Research Named Best Paper In Track for PharmaSug 2021
The paper “Standardizing Laboratory Data from Diverse Real-World Data was honored at the annual conference.
UBC’s Innovative Patient Recruitment Campaign Wins Award
UBC recently won an award from DrFirst for an innovative patient recruitment solution within a Phase III clinical trial for major depressive disorder.
The Value of Patient Support Programs During COVID-19
UBC and other industry experts spoke with PharmExcec.com about the impact a patient support program can have on patients and prescribers during a pandemic.
Strategies for Virtual and Decentralized Study Designs
UBC”s evidence development experts discuss how the COVID-19 global health crisis is impacting the future of virtual and decentralized studies.
UBC Cited in Publication for Smallpox Vaccine Safety Surveillance Study
“Learn more about this prospective study including the enrollment of 20,136 subjects who were active-duty military personnel.
